TY - JOUR
T1 - Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI
AU - Kreimer, Aimée R
AU - Chaturvedi, Anil K
AU - Alemany, Laia
AU - Anantharaman, Devasena
AU - Bray, Freddie
AU - Carrington, Mary
AU - Doorbar, John
AU - D'Souza, Gypsyamber
AU - Fakhry, Carole
AU - Ferris, Robert L
AU - Gillison, Maura
AU - Neil Hayes, D
AU - Hildesheim, Allan
AU - Huang, Shao Hui
AU - Kowalski, Luiz P
AU - Lang Kuhs, Krystle A
AU - Lewis, James
AU - Lowy, Douglas R
AU - Mehanna, Hisham
AU - Ness, Andy
AU - Pawlita, Michael
AU - Pinheiro, Maisa
AU - Schiller, John
AU - Shiels, Meredith S
AU - Tota, Joseph
AU - Mirabello, Lisa
AU - Warnakulasuriya, Saman
AU - Waterboer, Tim
AU - Westra, William
AU - Chanock, Stephen
AU - Brennan, Paul
N1 - Published by Elsevier Ltd.
PY - 2020/9/5
Y1 - 2020/9/5
N2 - Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.
AB - Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.
UR - http://www.scopus.com/inward/record.url?scp=85085648445&partnerID=8YFLogxK
U2 - 10.1016/j.oraloncology.2020.104736
DO - 10.1016/j.oraloncology.2020.104736
M3 - Article
C2 - 32502860
SN - 1368-8375
VL - 108
SP - 104736
JO - Oral Oncology
JF - Oral Oncology
M1 - 104736
ER -